Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drug development research

Showing results (291-300 of 1,376) with videos related to

Pageof 138
Sort By:
Drug Development Research|May 30, 2024
Hesperidin, vanillic acid, and sinapic acid attenuate atorvastatin-induced mitochondrial dysfunction via inhibition of mitochondrial swelling and maintenance of mitochondrial function in pancreas isolated mitochondriaAhmad Salimi, Saleh Khezri, Zoleikhah Vahabzadeh, et al.
Drug Development Research|June 7, 2024
Oxymatrine attenuates sepsis-induced inflammation and organ injury via inhibition of HMGB1/RAGE/NF-κB signaling pathwayJunbing He, Wanbing Qin, Shusong Jiang, et al.
Drug Development Research|July 20, 2024
A novel cinnamic and caffeic acid-conjugated peptide analogs with anticonvulsant and analgesic potency: Comparative analyses of trans/cis isomersJana Tchekalarova, Daniela Pechlivanova, Miroslav Rangelov, et al.
Drug Development Research|May 15, 2024
Identification of ROS and KEAP1-related genes and verified targets of α-hederin induce cell death for CRCGang Wang, Zhi-Min Zhu, Kun Wang
Drug Development Research|December 19, 2025
Targeted Delivery of Thymoquinone-Encapsulated Polyethyleneimine/Poly (Lactic Acid) Nanoparticles Into Breast Cancer CellsJeganpandi Senthamarai Pandi, Parasuraman Pavadai, Ewa Babkiewicz, et al.
Drug Development Research|December 23, 2025
Interface-Engineered Nanocarriers for Translational and Patient-Centric Topical Therapy in PsoriasisVivek Singh, Urushi Rehman, Taha Alqahtani, et al.
Drug Development Research|December 23, 2025
Pharmacological Evaluation of Novel N- and C-Modified Peptide Analogues of VV-hemorphin-5 and VV-hemorphin-7 as Potential Agents With Anti-Seizure ActivityJana Tchekalarova, Miroslav Rangelov, Nadezhda Todorova, et al.
Drug Development Research|December 17, 2025
Rational Design of Triazole Hydrazide Derivatives With Imidazo[2,1-b]thiazole Scaffolds as Targeted EGFR Inhibitors in NSCLCMohamed K Elgohary, Mahmoud S Elkotamy, Zainab M Elsayed, et al.
Drug Development Research|December 15, 2025
Esketamine Protects the Blood-Brain Barrier Against Sepsis-Associated Brain Injury by Regulating the BDNF/TrkB PathwayWeiqin Wei, Guofeng Wu, Yi Ge, et al.
Drug Development Research|November 30, 2025
Study on the Mechanism of Aspirin Alleviating Kawasaki Disease With Coronary Artery Lesions by Inducing TRAF6 to Regulate STAT3 Ubiquitination and Inhibit Th17 Cell DifferentiationXiangzhen Qu, Weina Ma, Xiujie Ma, et al.
Pageof 138

Showing results (291-300 of 1,376) with videos related to

Sort By:
Pageof 138
Drug Development Research|May 30, 2024
Hesperidin, vanillic acid, and sinapic acid attenuate atorvastatin-induced mitochondrial dysfunction via inhibition of mitochondrial swelling and maintenance of mitochondrial function in pancreas isolated mitochondriaAhmad Salimi, Saleh Khezri, Zoleikhah Vahabzadeh, et al.
Drug Development Research|June 7, 2024
Oxymatrine attenuates sepsis-induced inflammation and organ injury via inhibition of HMGB1/RAGE/NF-κB signaling pathwayJunbing He, Wanbing Qin, Shusong Jiang, et al.
Drug Development Research|July 20, 2024
A novel cinnamic and caffeic acid-conjugated peptide analogs with anticonvulsant and analgesic potency: Comparative analyses of trans/cis isomersJana Tchekalarova, Daniela Pechlivanova, Miroslav Rangelov, et al.
Drug Development Research|May 15, 2024
Identification of ROS and KEAP1-related genes and verified targets of α-hederin induce cell death for CRCGang Wang, Zhi-Min Zhu, Kun Wang
Drug Development Research|December 19, 2025
Targeted Delivery of Thymoquinone-Encapsulated Polyethyleneimine/Poly (Lactic Acid) Nanoparticles Into Breast Cancer CellsJeganpandi Senthamarai Pandi, Parasuraman Pavadai, Ewa Babkiewicz, et al.
Drug Development Research|December 23, 2025
Interface-Engineered Nanocarriers for Translational and Patient-Centric Topical Therapy in PsoriasisVivek Singh, Urushi Rehman, Taha Alqahtani, et al.
Drug Development Research|December 23, 2025
Pharmacological Evaluation of Novel N- and C-Modified Peptide Analogues of VV-hemorphin-5 and VV-hemorphin-7 as Potential Agents With Anti-Seizure ActivityJana Tchekalarova, Miroslav Rangelov, Nadezhda Todorova, et al.
Drug Development Research|December 17, 2025
Rational Design of Triazole Hydrazide Derivatives With Imidazo[2,1-b]thiazole Scaffolds as Targeted EGFR Inhibitors in NSCLCMohamed K Elgohary, Mahmoud S Elkotamy, Zainab M Elsayed, et al.
Drug Development Research|December 15, 2025
Esketamine Protects the Blood-Brain Barrier Against Sepsis-Associated Brain Injury by Regulating the BDNF/TrkB PathwayWeiqin Wei, Guofeng Wu, Yi Ge, et al.
Drug Development Research|November 30, 2025
Study on the Mechanism of Aspirin Alleviating Kawasaki Disease With Coronary Artery Lesions by Inducing TRAF6 to Regulate STAT3 Ubiquitination and Inhibit Th17 Cell DifferentiationXiangzhen Qu, Weina Ma, Xiujie Ma, et al.
Pageof 138